Veru (VERU) Net Equity Issued and Repurchased (2010 - 2026)
Veru (VERU) reported Net Equity Issued and Repurchased of -$23.37 million for fiscal Q3 2026 (quarter ended Jun 30, 2026).
Powered by 
Analysis
Veru (VERU) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Veru's Net Equity Issued and Repurchased came in at $1,000; for FY2024 (ended Sep 30, 2024), it was $3,280, down 99.2% from FY2023.
- Net Equity Issued and Repurchased has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -79.7% (FY2019 to FY2024).
- By fiscal year, Net Equity Issued and Repurchased came in at $400,000 in FY2023 (-63.6%), $1.1 million in FY2022 (-99.0%), $108.1 million in FY2021 and $415,464 in FY2020 (-95.6%).
- The fiscal Q3 2026 figure ranks as the lowest quarterly Net Equity Issued and Repurchased since fiscal Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Veru | 52.67 Mn | -57.60 Mn | - | -23.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.37 Mn |
| Dec 31, 2025 | 23.37 Mn |
| Jun 30, 2024 | -36.95 Mn |
| Mar 31, 2024 | -150,324.00 |
| Dec 31, 2023 | 37.11 Mn |
| Sep 30, 2023 | 63,390.00 |
| Jun 30, 2023 | -390.00 |
| Mar 31, 2023 | 79,868.00 |
| Dec 31, 2022 | 257,132.00 |
| Sep 30, 2022 | 689,000.00 |
| Jun 30, 2022 | 154,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Dec 31, 2021 | 210,000.00 |
| Sep 30, 2021 | 261,853.00 |
| Jun 30, 2021 | 238,147.00 |
| Mar 31, 2021 | 108.78 Mn |
| Dec 31, 2020 | 624,000.00 |
| Jun 30, 2020 | 6,832.00 |
| Sep 30, 2019 | 133,000.00 |
| Jun 30, 2019 | 3.60 Mn |
API Access
Veru Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VERU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();